Search Results 3661-3670 of 22458 for oral

  1. Hodgkin's Lymphoma Clinical Trials

    Venetoclax is an oral Bcl-2 family protein inhibitor. It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed ...

  2. Non Hodgkin's Clinical Trials - Mayo Clinic Research

    Venetoclax is an oral Bcl-2 family protein inhibitor. It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed ...

  3. Non Hodgkin's Clinical Trials - Mayo Clinic Research

    Venetoclax is an oral Bcl-2 family protein inhibitor. It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed ...

  4. De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA) - Mayo Clinic

    Patients that discontinue oral, transdermal, or subdermal estrogen replacement prior to registration are eligible. Prior breast or thoracic RT for any ...

  5. Financial Assistance Documents — Florida campus - Mayo Clinic

    Supporting documents for those unable to pay for medically necessary care at Mayo Clinic's Florida campus.

  6. To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active Chronic Inflammatory Demyelinating Polyneuropathy - Mayo Clinic

    Are receiving chronic oral corticosteroids monotherapy at a dose > 40 mg/day or < 20 mg/day prednisolone/prednisone or its equivalent at the Screening Visit.

  7. Eric J. Dozois, M.D. - Doctors and Medical Staff - Mayo Clinic

    Oral ExaminerAmerican Board of Colon and Rectal Surgery. 2009 - 2014. MemberOperative Competency Evaluation Committee, American Society of Colon and Rectal ...

  8. After Facial Surgery, Tammy Says Goodbye to Years of Sleep Apnea - Mayo Clinic News Network

    After meeting Christopher Viozzi, M.D., D.D.S., a Mayo Clinic oral and maxillofacial surgeon, however, Tammy found the help she so desperately needed. Tammy ...

  9. Robert D. McBane, II, M.D. - Mayo Clinic Faculty Profiles

    Each of these trials has assessed the efficacy and safety of direct oral anticoagulants compared with low-molecular weight heparin for patients with cancer.

  10. Publications - Jenny F. Yang, M.D. - Mayo Clinic

    J Oral Maxillofac Surg. 2021 Aug; 79 (8):1733-1742 Epub 2021 Mar 08. View PubMed; Cabrejo R, Lacadie C, Sun A, Chuang C, Yang J, Brooks E, Beckett J, Eilbott ...